Abbott's Knoll Advantage
Executive Summary
The recent launch of Humira is the clearest sign of how valuable the Knoll acquisition has proved for Abbott. Yet the deal's rewards have come not only from the assets Knoll had to offer, but from what Abbott chose to do with them.